These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49 related articles for article (PubMed ID: 7486202)
1. [Use of antibiotic thienam in critical care patients]. Mariutin PV; Uchvatkin VG Anesteziol Reanimatol; 1995; (4):67-8. PubMed ID: 7486202 [No Abstract] [Full Text] [Related]
2. [Effectiveness of and tolerance to intramuscular imipenem in the treatment of infections of different severities]. Bicocchi R; Libanore M; Carradori S; Catalini MG; Di Giandomenico G; Gritti FM; Ghinelli F G Ital Chemioter; 1991; 38(1-3):177-9. PubMed ID: 1365584 [No Abstract] [Full Text] [Related]
3. [Thienam treatment in early postoperative period after pneumonectomy in patients with lung cancer]. Potanin VP; Taziev RM; Sigal EI; Krasin VV; Khalimov ID; Potanin AV; Sigal RI; Latypov AG Khirurgiia (Mosk); 2001; (10):47-8. PubMed ID: 11763820 [No Abstract] [Full Text] [Related]
4. Imipenem + cilastatin--a new type of antibiotic. Drug Ther Bull; 1991 May; 29(11):43-4. PubMed ID: 1935582 [No Abstract] [Full Text] [Related]
5. [Experience in the use of imipenem/cilastatin (thienam) in a surgical clinic]. Briskin BS; Khachatrian NN; Nekrasova NI; Kuznetsov EV; Suplotova AA; Sosnovikova OG Khirurgiia (Mosk); 2000; (9):56-61. PubMed ID: 11026205 [No Abstract] [Full Text] [Related]
6. Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia. Bartoloni A; Strohmeyer M; Corti G; Buonomini MI; Franchino L; Romanelli G; Moretti AM; De Vizzi GB; Petraglia A; Mancini P; Atzeni R; Fogliani V; Giura R; Paradisi F Drugs Exp Clin Res; 1999; 25(6):243-52. PubMed ID: 10713862 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic profiles of intravenous imipenem/cilastatin during slow hemodialysis in critically ill patients. Kihara M; Ikeda Y; Shibata K; Masumori S; Ebira H; Shiratori K; Ueda S; Takagi N; Umemura S; Shionoiri H Clin Nephrol; 1994 Sep; 42(3):193-7. PubMed ID: 7994939 [TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies. Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671 [TBL] [Abstract][Full Text] [Related]
10. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections. Cakmakci M; Stern A; Schilling J; Christen D; Roggo A; Geroulanos S Drugs Exp Clin Res; 1993; 19(5):223-7. PubMed ID: 8174495 [TBL] [Abstract][Full Text] [Related]
11. [A trial of the clinical use of thienam in treating severe and life-threatening suppurative-septic complications]. Grinev MV; Shapot IuB; Tsibin IuN; Gal'tseva IV; Chiritso BG Vestn Khir Im I I Grek; 1996; 155(4):54-6. PubMed ID: 8992722 [TBL] [Abstract][Full Text] [Related]
12. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients. Kuo BI; Fung CP; Liu CY Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):361-7. PubMed ID: 10862445 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients. Miller JA; Butler T; Beveridge RA; Kales AN; Binder RA; Smith LJ; Ueno WM; Milkovich G; Goldwater S; Marion A Clin Ther; 1993; 15(3):486-99. PubMed ID: 8364941 [TBL] [Abstract][Full Text] [Related]
14. [Selective intraarterial application of Thienam and Vasoprostan in the treatment of purulent foot diseases in patients with diabetes mellitus]. Antsypovich EA; Molchanov VF; Kadyshev IuG; Brusnitsyna MA Klin Khir; 1998; (8):53. PubMed ID: 9866335 [No Abstract] [Full Text] [Related]
15. [Selective intra-arterial use of small doses of thienam and vasaprostanin the treatment of suppurative diseases of the foot in patients with diabetes mellitus]. Antsypovich EA; Molchanov VF; Kadyshev IuG; Brusnitsyna MA Vestn Khir Im I I Grek; 1998; 157(1):76-7. PubMed ID: 9611324 [TBL] [Abstract][Full Text] [Related]
16. [Efficacy of imipenem-cilastatin in combined therapy of severe anaerobic-aerobic infection of bones and soft tissues]. Goriunov SV; Romashov DV; Butivshchenko IA; Il'ianina AA; Mikhal'skiĭ VV; Rog AA; Polikarpova SV Khirurgiia (Mosk); 2002; (7):50-6. PubMed ID: 12162087 [No Abstract] [Full Text] [Related]
17. [The use of thienam for the emergency antibacterial therapy of acute suppurative pyelonephritis]. Pasiechnikov SP; Pohrebyns'kyĭ VM; Rudenko AV; Mitchenko MV Lik Sprava; 1997; (1):84-7. PubMed ID: 9221156 [TBL] [Abstract][Full Text] [Related]
18. Imipenem-cilastatin-induced leukocytoclastic vasculitis. Reiner MR; Brunetti VA J Am Podiatr Med Assoc; 1997 May; 87(5):245-7. PubMed ID: 9158321 [TBL] [Abstract][Full Text] [Related]
19. [Efficacy and tolerance of imipenem/cilastatin in the adjuvant treatment of surgery for peritonitis in patients over the age of 70 years]. Janvier G; Carles J Ann Chir; 1993; 47(4):370-5. PubMed ID: 8352517 [TBL] [Abstract][Full Text] [Related]